LFCR Earnings

Quarterly EPS
$-0.53
Q2 2025
$-0.42
Q4 2025
$-0.06
Q1 2025
$-0.29
Q2 2026
$-0.29
Q3 2025
$-0.43
Q4 2026
$-0.19
Q1 2027
$-1.08
Q3 2026
Latest Revenue25.3M
Latest Net Income-40084000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$1.0825.3M-40084000-18.6%-272.4%
Q1 2027-$0.1934.2M-6156000-6.2%-216.7%
Q4 2026-$0.4323.2M-14980000-34.0%-2.4%
Q3 2025-$0.2931.1M-9991000+25.9%+45.3%
Q2 2026-$0.2931.1M-9991000-17.9%-26.1%
Q1 2025-$0.0636.4M-1147000+2.1%-111.8%
Q4 2025-$0.4235.2M-14769000+16.6%-189.4%
Q2 2025-$0.5324.7M-16230000+0.7%-51.4%
Q4 2024-$0.2337.9M-7083000——
Q3 2024$0.5135.7M15.6M——
Q2 2024$0.4730.1M14.2M——
Q1 2024-$0.3524.5M-10754000——
Lifecore Biomedical (LFCR) — Earnings